about
Tonsillectomy as a treatment for psoriasis: a reviewExpression of human solute carrier family transporters in skin: possible contributor to drug-induced skin disorders.Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus.Expression pattern of human ATP-binding cassette transporters in skin.Trends in incidence of adult-onset psoriasis over three decades: a population-based study.The importance of disease associations and concomitant therapy for the long-term management of psoriasis patientsDrug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score.Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities.Psoriasis aggravation due to lapatinibWhat is a role of haeme oxygenase-1 in psoriasis? Current concepts of pathogenesis.Incidence of psoriasis in children: a population-based studyLithium and psoriasis: what primary care and family physicians should know.A rare side effect seen due to the use of apixaban: Palmoplantar psoriasiform drug eruptionEarly intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper.Psoriasiform drug eruption associated with sodium valproate.Psoriasiform Diaper Rash Possibly Induced by Oral Propranolol in an 18-Month-Old Girl with Infantile Hemangioma.Triggering drug use in patients with psoriasis: an investigative report from TurkeyDrug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.[Trigger factors for psoriasis].Pro-oxidant status and Nrf2 levels in psoriasis vulgaris skin tissues and dimethyl fumarate-treated HaCaT cells.Olanzapine-induced Psoriasis.Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study.Treating pediatric plaque psoriasis: challenges and solutions.Drug-induced psoriasis: results from pharmacovigilance tools under investigation.Drug-induced psoriasis: clinical perspectives.Current knowledge on psoriasis and autoimmune diseases.Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease.Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimodNo increased risk of psoriasis in patients receiving androgen deprivation therapy for prostate cancer: a 17-year population-based study
P2860
Q22305701-4D9C9881-1262-4D0C-A4B3-186A75888AFDQ33737892-216B151E-A713-4294-A1B5-E01C61A75915Q33782011-DCAE4A4C-E395-4F39-AB86-260DC592EEBFQ34286447-89D987F9-F5FF-4E69-BC8E-AC305A84E9F5Q34527982-7B492A28-555F-440C-9459-AC811A2FF3EAQ35230117-CDD352EE-B1B4-45BE-AA30-CD443476617DQ36479485-76B92FF8-1E42-4FF5-853F-773010C396B3Q36552806-E2225304-8068-40BF-A7EA-8AB0EEDD9E46Q36704672-B5693DBB-4230-4E7B-B012-0ACE98B1DEF5Q36780173-2468DF7C-737B-4A39-BEA4-B41728464A25Q37283640-94FC47DB-C23D-46AC-A5E7-5362C463163FQ37415311-6F8EDB40-DDEB-4EF3-9282-CBC7EE0E6BABQ37680369-4D1394ED-BCFC-4FEC-913D-EC721F348A8DQ38189108-5846E00A-0E0A-4106-A112-423F4223F548Q41877874-AFBC41F3-F6A9-4155-9E70-0DF3B94AAB2EQ41896159-88BBD78E-2C73-4A8F-AE48-82FF5C208354Q41919861-DB6C1FEF-BF11-4FDD-BA3B-CB57F9D1F6AEQ42534194-0380F9D0-E5E9-4410-9DC0-67EF83D0E0AFQ44360564-3FBA0483-8552-4003-90D9-8CE6B6F8216CQ46305804-1A6D31DD-DAAC-4641-92AA-8EAF96EC6E17Q47127807-0A39100A-4A2C-44F1-A9A5-44AAA2EA08E3Q47375056-12AF9F04-0FCB-485B-A0F4-3BD30663C710Q49500717-4B7DCAD1-ED45-4F94-B77E-3996D07DFE2DQ51891331-11519608-803F-4911-993C-3F1DE6E7D428Q52701370-B6BE8AA6-AF82-47FA-95C0-A7D3E8028A78Q55044800-99129447-EFA5-4A23-B35D-F1A6FE85ECD0Q55315725-9E942A70-84D0-4670-9616-85783B27AFCCQ56679622-0DDC0F5F-5D96-488A-8B41-C7448F3DD948Q57490622-0A30A1C6-1137-40CC-8A52-56B82FEA17A7
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Drug-induced psoriasis. Recognition and management.
@ast
Drug-induced psoriasis. Recognition and management.
@en
Drug-induced psoriasis. Recognition and management.
@nl
type
label
Drug-induced psoriasis. Recognition and management.
@ast
Drug-induced psoriasis. Recognition and management.
@en
Drug-induced psoriasis. Recognition and management.
@nl
prefLabel
Drug-induced psoriasis. Recognition and management.
@ast
Drug-induced psoriasis. Recognition and management.
@en
Drug-induced psoriasis. Recognition and management.
@nl
P2093
P1476
Drug-induced psoriasis. Recognition and management.
@en
P2093
Angelova I
Kazandjieva J
P304
P356
10.2165/00128071-200001030-00003
P577
2000-05-01T00:00:00Z
P6179
1018606568